Phenotype of CM-AVM2 caused by variants in EPHB4: how much overlap with hereditary hemorrhagic telangiectasia (HHT)?

[1]  A. Presson,et al.  Epistaxis in children and adolescents with hereditary hemorrhagic telangiectasia , 2018, The Laryngoscope.

[2]  A. Berenstein,et al.  Expanding the clinical and molecular findings in RASA1 capillary malformation-arteriovenous malformation , 2018, European Journal of Human Genetics.

[3]  R. Kasthuri,et al.  Applicability of the Curaçao Criteria for the Diagnosis of Hereditary Hemorrhagic Telangiectasia in the Pediatric Population , 2018, The Journal of pediatrics.

[4]  Cynthia J. Grondin,et al.  Loss of function mutations in EPHB4 are responsible for vein of Galen aneurysmal malformation , 2018, Brain : a journal of neurology.

[5]  W. Chung,et al.  Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK Signaling , 2017, Circulation.

[6]  I. Krantz,et al.  EPHB4 Mutation Implicated in Capillary Malformation–Arteriovenous Malformation Syndrome: A Case Report , 2017, Pediatric dermatology.

[7]  E. Chao,et al.  Mutations in RASA1 and GDF2 identified in patients with clinical features of hereditary hemorrhagic telangiectasia , 2015, Human Genome Variation.

[8]  P. Bayrak-Toydemir,et al.  Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era , 2015, Front. Genet..

[9]  Brendan D. O'Fallon,et al.  BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. , 2013, American journal of human genetics.

[10]  P. Bayrak-Toydemir,et al.  RASA1 analysis: clinical and molecular findings in a series of consecutive cases. , 2012, European journal of medical genetics.

[11]  R. Pyeritz,et al.  Hereditary hemorrhagic telangiectasia: An overview of diagnosis, management, and pathogenesis , 2011, Genetics in Medicine.

[12]  P. Bayrak-Toydemir,et al.  Mosaic ACVRL1 and ENG mutations in hereditary haemorrhagic telangiectasia patients , 2011, Journal of Medical Genetics.

[13]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[14]  Jana Marie Schwarz,et al.  MutationTaster evaluates disease-causing potential of sequence alterations , 2010, Nature Methods.

[15]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[16]  A. Guttmacher,et al.  International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia , 2009, Journal of Medical Genetics.

[17]  R. Durbin,et al.  Mapping Quality Scores Mapping Short Dna Sequencing Reads and Calling Variants Using P

, 2022 .

[18]  J. Mulliken,et al.  Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast‐flow vascular anomalies are caused by RASA1 mutations , 2008, Human mutation.

[19]  J. Mulliken,et al.  RASA1: variable phenotype with capillary and arteriovenous malformations. , 2005, Current opinion in genetics & development.

[20]  Miikka Vikkula,et al.  Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. , 2003, American journal of human genetics.

[21]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[22]  A. Guttmacher,et al.  Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). , 2000, American journal of medical genetics.

[23]  C. Ko,et al.  Histopathologic and Ultrasound Characteristics of Cutaneous Capillary Malformations in a Patient with Capillary Malformation–Arteriovenous Malformation Syndrome , 2015, Pediatric dermatology.

[24]  Claude-Alain H. Roten,et al.  Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..